Cat scratch disease (CSD) is a benign disease characterized by fever, self-limited regional lymphadenitis, and skin lesions due to cat scratch or bite. CSD shows a worldwide distribution and has been mostly reported in children aged less than 18 yr of age. The etiologic agent of CSD is Bartonella henselae, a gram-negative rod [1] . Little is known about the epidemiology of CSD in Korea. Since B.
known about the epidemiology of CSD in Korea. Since B.
henselae is fastidious and cannot be grown in cultures, only 2 CSD cases have been reported using molecular genetic methods in Korea [2, 3] . Here, we present the third case of CSD in a Korean pediatric patient; the disease was confirmed using PCR and DNA sequencing with primers recently described in the literature.
In September 2008, an 8-yr-old girl presented with enlargement of both axillary lymph nodes and fever that had persisted for 2 weeks. The patient had received all the recommended immunizations. A month before her admission, a cat had scratched her on the right subclavicular area. Investigation of her family history revealed that her grandmother had been diagnosed with pulmonary tuberculosis.
Physical examination of the patient revealed a 2×2 cm mass on the right axillary lymph node and a 3.5×3 cm tender and slightly movable mass on the left axillary lymph node. The skin on the right chest wall showed papular lesions. The liver, spleen, or other lymph nodes did not show any apparent enlargement. Yellowish pus was exuded from the left axillary lymph node.
The initial complete blood cell count showed that the WBC count was 14,710/mL; platelet count, 445,000/mL; and hemoglobin level, 11.1 g/dL. Mycobacterium tuberculosis antigen-specific interferon-gamma release assay of her serum sample by using QuantiFERON 
34
We report a case of cat scratch disease in an 8-yr-old girl who presented with fever and enlargement of both axillary lymph nodes. Both aerobic and anaerobic cultures of the lymph node aspirate were negative for microbial growth. Gram staining and Warthin-Starry silver staining did not reveal any organism. Purified DNA from the PCR-amplicon of the 16S-23S rRNA intergenic region was sequenced and showed 99.7% identity with the corresponding sequence of Bartonella henselae strain Houston-1. Our findings suggest that the internal transcribed spacer is a reliable region for PCR identification of Bartonella species. In patients with lymphadenitis, a history of contact with cats or dogs necessitates the use of diagnostic approaches that employ not only the conventional staining and culture but also molecular methods to detect B. henselae. DNA was extracted from the aspirate using QIAamp DNA Tissue Mini kit (QUIAGEN, Hilden, Germany). We performed PCR of the purified template DNA using primers described by Jensen et al. [4] and Maggi and Breitschwerdt [5] . The primers reported by Maggi and Breitschwerdt [5] targeted 2 consensus regions of the 16S-23S rRNA intergenic spacer region (ITS) of Bartonella species, whereas the primers described by Jensen et al. [4] targeted only 1 region of ITS [4] . Universal 16S rRNA primers were used as the internal control [6] . PCR amplification with the primers described by Maggi and Breitschwerdt [5] In immunocompetent children and adolescents, CSD is usually self-limiting and does not require any antibiotic treatment. However, azithromycin has shown clinical efficacy [7] , as in our case. The atypical symptoms of CSD such as bacillary angiomatosis, bacillary peliosis hepatis, Parinaud' s oculoglandular syndrome, encephalopathy, endocarditis, and bacteremia may progress to more serious consequences in 5-20% of CSD patients [8] . Although some of these symptoms are fatal if left untreated, a treatment protocol for atypical CSD has still not been established because of the lack of epidemiologic, clinical, and diagnostic data [8] . To date, CSD is underdiagnosed in many countries, probably because of the difficulty in isolation with conventional culture [9] . CSD misdiagnosis is another potential risk and may lead to unnecessary treatment [8] . Therefore, clinical recognition and accurate diagnosis of CSD is essential.
The clinical diagnosis of CSD is based on the detection of an enlarged lymph node and possibly a skin lesion at the contact site. Clinicians should investigate the patient' s contact history with cats, dogs, rodents, fleas, ticks, or other blood sucking arthropods. The laboratory diagnostic approaches include culture, histological, serological, and molecular methods [10] .
The sample is cultured on blood agar containing 5% sheep or horse blood and 100 mg/L hemin and incubated in 5% CO2 at 37℃. B. henselae grows slowly, and a primary isolate is typically obtained in about 12-14 days.
However, the culturing of Bartonella is still a complicated process; therefore, only a small number of CSD cases have been diagnosed using this approach [11] . In our study, we inoculated the sample on blood agar and chocolate agar plates and incubated them for 4 weeks, but no Bartonella growth was detected. In addition to culturing, the aspirate or biopsy specimen may be subjected to histopathologic examination after staining with Warthin-Star-Borum Suh, Jin-Kyoung Chun, Dongeun Yong, et al.
ry silver stain, which is neither highly specific nor sensitive for Bartonella species [10] .
The serological methods for diagnosis indicate seroconversion or significant increase in the serum anti-B. henselae antibody titer within 15 days. However, the commercialized serological diagnostic kits do not yield consistent results, and the sensitivity of these kits are lesser than those of molecular methods [12] .
Since B. henselae cannot be detected using culture or histology and serological tests lack sensitivity, a confirmatory diagnosis of CSD is essentially based on PCR [10] .
Lymph node aspirate can be easily obtained by fine-needle aspiration, thereby obviating the need for an excision biopsy. Molecular methods have successfully identified the causative organism to the strain-specific level with enhanced sensitivity and specificity [13] .
The initial PCR performed using DNA extracted from 0.1 mL of pus specimen was negative for all the abovedescribed primers. A second PCR performed with DNA extracted from 1 mL of pus specimen showed bands of the expected sizes with both Maggi and Breitschwerdt primers [5] ; the absence of these bands in the first PCR may be attributed to the insufficient amount of template DNA to overcome the PCR inhibitors in the pus specimen [14] .
In our study, the internal control (universal 16S rRNA primer) did not show any amplification. To determine the reason for this finding, we aligned the 16S rRNA primer sequence with the nucleotide sequence of B. henselae and found that only the forward primer had a matching sequence alignment. Although this primer was designed to target the conserved 16S rRNA sequence common to most bacterial species, it failed to identify the 16S rRNA sequence of B. henselae. Moreover, since the 16S rRNA genes of Bartonella spp. show more than 97.8% similarity [13] , the 16S rRNA gene may not be a suitable target for Bartonella species identification.
This is the third reported case of cat scratch disease that was confirmed by PCR for B. henselae in Korea. The 2 previous reports had used the primer sets for the gltA gene described by Margolis et al. [15] and the primer sets for the pap31 gene described by Zeaiter et al. [14] , which employed nested PCR. However, in comparison to conventional PCR, nested PCR is more cumbersome, and the samples are prone contamination; thus, this approach may not be widely applicable. Therefore, we used conventional PCR to amplify the extracted template DNA with primers described by Maggi and Breitschwerdt [5] , which targetted the 16S-23S rRNA ITS region.
In Korea, few clinical or epidemiological studies on B.
henselae have been performed; the dearth of studies can be attributed to the absence of established diagnostic methods and the lack of clinical recognition for B. henselae infections. CSD can be overlooked or misdiagnosed in the absence of proper molecular diagnostic tools. Therefore, clinicians must consider CSD while diagnosing a patient presenting with lymphadenopathy and/or fever and thoroughly investigate the patient' s contact history with cats or dogs. As the incidence of CSD increases, appropriate diagnostic tools that can be widely applied in clinical epidemiology may be established.
